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POLYMERASE
CHAIN REACTION
IN CLINICAL PRACTICE
Sujatha Narayanan
One of the most heralded develop-
ments in basic science to reach clinical appli-
cation in recent years has been the Poly-
merase Chain Reaction (PCR).
PCR has been applied in various areas
of clinical medicine including rapid diagno-
sis of viral, bacterial, fungal and parasitic
disease, the diagnosis and prediction of inher-
ited disease, the detection of an association
between certain viruses and specific cancers,
the detection of organ transplant rejection and
HLA subtyping. In basic research PCR is
useful in identification of point mutation,
deletion, insertions, rearrangements, amplifi-
cations and translocations.
Diagnostic PCR is a technique of DNA
amplification that uses specific DNA se-
quences to serve as markers for the presence
ofmicroorganisms and is in theory capable of
detecting a single organism in a biologic
specimen such as sputum, lavage fluid, cere-
brospinal fluid, pleural fluid, blood or any
other specimen including nail and hair1.
Types of PCR
Numerous modifications of the stan-
dard PCR procedure have been developed
since its inception2-4.
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1. Reverse-transcriptase (RT) PCR was
developed to amplify RNA targets. RT PCR
has played a important role in diagnosing
RNA containing virus infections, detecting
viable mycobacteria species and monitoring
the effectiveness of antimicrobial therapy.
Commercial kits are now available for detec-
tion of HIV using single new enzyme (DNA
polymerase Tth pol) technology.
2. Nested PCR designed mainly to in-
crease sensitivity uses two sets of amplifica-
tion primers2,5. One set of primers is used for
the first round of amplification and the ampli-
fication products of the first round are sub-
jected to a second round of amplification with
another set of primers. Nested PCR has ex-
tremely high sensitivity because of dual set of
amplification process.
3. Multiplex PCR in which two or more
sets of primers from the same organism or
even different organism are introduced into
the same tube. This increases the sensitivity
as well as cuts cost.
4. Broad range PCR: Another impor-
tant technical modification is the develop-
ment of broad-range PCR in which conserved
sequences within phylogenetically informa-
tive targets are used to diagnose microbial
infection. This technique has identified sev-
eral fastidious or uncultivatable bacterial
pathogens directly from infected human tis-
sue or blood. There are other amplification
methods like ligase chain reaction, QB repli-
case system and strand displacement amplifi-
cation which has not been evaluated on a large
scale2.
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PCR is very useful to detect the micro-
organisms which are either unculturable or
extremely fastidious or hazardous to labora-
tory personnel. PCR has made it easy to detect
such organisms directly from inactivated clini-
cal specimens without exposing the labora-
tory personnel to live organisms. PCR has
been successfully used in clinical and epide-
miological investigations and control of
emerging nosocomial pathogens such as
Pseudomonas aerugenosa, Staphylococcus
aureus, coagulase-negative Staphylococci,
Enterococci, Chlamydia pneumoniae6-8 and
Candida albicans and viruses like respiratory
syncytial virus, varicella zoster virus, herpes
simplex virus and legionella. The ability to
rapidly and unambiguously characterise or-
ganisms suspected of causing a disease out-
break is critical to public health and hospital
infection-control endeavors.
Robert Wadowsky9 have recommended
a multiplex PCR assay for the detection of
Bordetella pertussis in nasopharyngeal swab
specimens. Van eys10 was first to develop
PCR for detection of leptospires in urine
samples. The samples containing as little as
10 leptospires give positive results. Diagnos-
tic laboratories all around the world are in-
creasingly faced with challenge of detecting
rabies virus(RV) and rabies related (RRV)
viruses. A hemi nested reverse transcriptase
PCR protocol is more sensitive to florescent
antibody test (FAT) which is the commonly
used test because it is able to detect RV even
in the decomposed brain tissue whereas FAT
can detect only when the brain tissue is fresh.
A multiplex PCR procedure was devel-
oped for the simultaneous detection of
Alloicoccus otitidis. Haemophilus influenza,
Moraxella catarrhalis and Streptococcus
pneumoniae in the middle ear effusions from
patients with chronic otitis media with effu-
sion. By conventional culture method 8 (32%)
of the specimens showed growth of one of the
organisms tested in contrast 21 (84%) of the
specimens tested positive by the multiplex
PCR11. The advent of DNA based methods for
causative organisms may improve the diag-
nostic yield in cases of culture negative
endocarditis. However, the sensitivity and
specificity and positive predictive value of
these new technologies is unknown and like
serology the result should be interpreted with
caution.
PCR has become popular in the field of
tuberculosis diagnosis, because the conven-
tional methods are less sensitive and time
consuming. For example smear microscopy
is less sensitive with a limitation that only
when a patient excretes 25000 bacilli in spu-
tum it can detect, and it takes 4 weeks to
culture M. tuberculosis Tuberculosis is the
largest killer among the infectious diseases.
With the emergence of HIV epidemic and
multidrug resistance there is utmost necessity
to improve diagnostic methods of Mycobac-
terium tuberculosis using advanced molecu-
lar methods. PCR has a lot of promise to offer
in the detection of extra pulmonary tubercu-
losis where culture, which is the gold stan-
dard, often fails to detect the organism. The
great potential of PCR in diagnosing tubercu-
losis was revealed particularly in relation to
speed and sensitivity.
The commercial PCR assay recently
being evaluated (Amplicor Roche Molecular
Systems, Somersille, New Jersey) is based on
amplification of a 584 bp region of the gene
encoding 16sRNA. This approach could per-
mit simultaneous testing for several species
of mycobacteria in a single assay using a
series of species-specific oligonucleotide in
separate wells. Recent publications have de-
scribed the various evaluation experiments
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undertaken using respiratory specimens12-14.
As was the case with the research assays the
sensitivity with smear positive specimens was
excellent around 95% but with smear nega-
tive/culture positive specimens, the sensitiv-
ity was lower. However some culture nega-
tive samples are positive by PCR. Analysis of
these samples suggest that they are not false
positive.
The risk of false positive results due to
carry over of target DNA from a positive to a
negative sample is probably the single great-
est hurdle that is in the way of the clinical
application of PCR diagnosis. The extremely
high sensitivity afforded by exponential am-
plification of DNA, which renders it very
powerful also exposes it to the risk of con-
tamination by minute quantities ofexogenous
DNA. Contaminating DNA may come from
clinical specimens containing large numbers
of target molecules from bacterial cultures
sometimes used as positive control in mo-
lecular tests or from plasmid DNA generated
in cloning specific M. tuberculosis DNA se-
quences. Most frequently the problem arises
from the accumulation in the laboratory of
PCR amplicons. False positive results can be
avoided by following a number of specific
precautions including physical isolation of
pre and post amplification procedures, the use
of disposable materials (gloves, sterile aero-
sol-resistant tips) pre aliquoted reagents, and
dedicated positive- displacement pipettes, to-
gether with careful choice of negative and
positive controls. An enzymatic method us-
ing an uracil-N-glycosylase and substituting
dUTP instead of dTTP in the PCR and photo-
chemical method with psoralen has been ad-
vocated to reduce false positivity. Just like
false positivity, PCR can report false negative
results due to presence of exogenous inhibi-
tors like anticoagulants and detergents and
endogenous inhibitors in clinical specimens.
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DNA processing methods can be improved to
remove inhibitors of PCR. The assay is rela-
tively expensive and technically demanding
and is mainly recommended for use in special
laboratories15,16.
What is the role of molecular diagnosis
is the clinical management of suspect tuber-
culosis cases? A recent commentary of the
American Journal of Respiratory and Critical
Care Medicine17,18 cautioned against the use
of PCR in the clinical setting. Sensitivity,
specificity and predictive power of the PCR
test then contended are not significantly higher
than fluorescent microscopy and cultures in
selective media.
PCR testing for M. tuberculosis is a
rapidly evolving research area. There are dif-
ficulties with the interpretation of available
studies due to the variety of criteria used for
patients selection and of procedures used for
microbiology as well as molecular testing.
Most importantly however the gold standard
test for the diagnosis of tuberculosis is not
solid gold with extrapulmonary tuberculosis
cases as well as the sharp rise observed in the
members o f  p a t i e n t s , most often
immunocompromised with paucibacillary
tuberculosis. These are the ones who may go
without microbiological diagnosis until au-
topsy e.g. tuberculosis in HIV patients.
The evidence that PCR diagnostic test-
ing is useful for diagnosis of tuberculosis is
quite convincing. PCR testing will definitely
improve the diagnosis of tuberculosis in pa-
tients with atypica l  presenta t ion ,
extrapulmonary tuberculosis, treated with an-
tibiotics and in immunodeficient patient.
Reliability of PCR for detection of
Hepatitis C virus has been tested by perform-
ing double blind study in 31 laboratories by
HCV RNA detection. HCV PCR should be
211
I.A.P. Journal of Practical Pediatrics
interpreted with caution. Similar evaluation
done on HBV PCR also warrants careful
interpretation of PCR results. Reliability of
PCR for detection of M. tuberculosis have
been tested by Noordheck et al., who con-
ducted a quality control double blind study
giving coded samples to 30 laboratories and
analysing the results 19. There again only 5
laboratories were perfectly correct. This
clearly shows PCR cannot be ignored as a
useless test. But quality control should be
emphasized. Right now PCR can be per-
formed only in specialised laboratories by
trained people. PCR can be definitely advo-
cated as an additional test for extrapulmonary
tuberculosis and other paucibacillary speci-
mens as long as the interpretation of the
results are done along with the relevant clini-
cal criteria.
References
1. Einstein B. The polymerase chain re-
action. A new diagnostic method of
using molecular genetics for medical
diagnosis. N Engl J Med 1990; 322:
178-183.
2. Elrich HA, Gelfard D, Srinsky JJ. Re-
cent advances in the polymerase chain
reaction (Review). Science 1991,252:
1643-1651.
3. Persing DH. Polymerase chain reac-
tion: trenches to benches (Review). J
Clin Microbiol 1991, 29 : 1281-1285.
4. Wagar EA. Direct hybridisation and
amplification applications for the di-
agnosis of infectious diseases (Review).
J Clin Lab Anal 1996, 10 : 312-325.
5. Haqqi TM, Sarkar G, David CS, Somer
SS. Specific amplification of a refrac-
tory segment of genomic DNA. Nucleic
Acids Res 1988, 16 : 1184.
6. Banerjee SN, Emori TG, Culver DH,
212
Gaynes RP, Jarvis WR, Horan T. et al.
Secular trends in nosocomial primary
blood stream infections in the United
States, 1980-1989. Am J Med 1991,
91 : 86S-98S.
7. Pfaller MA, Wenzel RP. Impact of the
changing epidemiology of fungal in-
fections in the 1990s. Eur J Clin
Microbiol Infect Dis 1992, 11 : 289.
8. Troy CJ, PeelingRW, Ellis AG, Hockin
JC, Bennett DA, Murphy MR, Spika
JS. Chalmydia pneumoniae as a new
source of infectious outbreaks in nurs-
ing homes. JAMA 1997, 277 : 1214-
1218.
9. Robert M, Wadowsky, Richard H,
Michaels, Therese Libert, Laowrence
A, Kingsley and Garth D. Ehrlich.
Multiplex PCR-based assay for detec-
tion of Bordetella pertussis in Naso-
pharyngeal swab specimens. J Clin
Microbiol 1996, 34 : 2645-2649.
10. Van Eys J Clin Microbiol 1989, 27:
2254-2258.
11. Panu H, Hendolin, Aila Markkanen,
Jukka Ylikoski, J Jarmo Wahlfors. Use
of multiplex PCR for simultaneous de-
tection of 4 bacterial species in middle
ear effusions. J Clin Microbiol 1997,
35 : 11, 2854-2858.
12. Beavis KG, Lichty MB, Jungkind DL,
Giger O. Evaluation of Amplicor PCR
for direct detection of M. tuberculosis
from sputum specimens. J Clin
Microbiol 1995, 33 : 2582-2586.
13. Moore DF, Curry JL. Detection and
identification of M. tuberculosis directly
from sputum sediments by Amplicor
PCR. J Clin Microbiol 1995; 33 : 2686-
2691.
14. Granato PA, Franz MR. Use of the
Gen-probe PACE system for the detec-
tion of Neisseria gonorrhoeae in uro-
genital samples. Diag Microbiol Infect
Dis 1990, 3 : 217-221.
15. Longo MC, Berminger MS, Hartley
JC. Use or uracil DNA glycosylase to
control carry over contamination on
polymerase chain reaction. Gene 1990,
93 : 125-128.
16. Cimino GD, Metchette KC, Tessman
JW, Hearst JE, Isaacs ST. Post PCR
sterilisation, a method to control carry
over contamination for the polymerase
chain reaction. Nucleic Acids Res 1991,
19 : 99-107.
Vol. 6 No.3, JUL.-SEP. 1998
17. Schluger WW, Rom WN. Current ap-
proaches to the diagnosis of active pul-
monary tuberculosis. Am J Respir Crit
Care Med 1994, 149 : 264-267.
18. Clarridge III JE, Shawar RM, Shermich
TM, Plikayte BB. Large scale use of
polymerase chain reaction for detec-
tion of M. tuberculosis in a routine
mycobacteriology laboratory. J Clin
Microbiol 1993, 31L 2049-2056.
19. Noordhoek GT, Kolk AHJ, Bjune G,
Catty D, Dale JW, Fine PEM Sensitiv-
ity and specificity of PCR for detection
of M. tuberculosis: A blind comparison
study among 30 laboratories. J Clin
Microbiol 1994, 32 : 277-284.
213
